Least Invasive Surgery for Prostate Cancer

Least Invasive Surgery for Prostate Cancer

Dr Samadi’s technique builds on oncologic principles learned with open radical prostatectomy and transferred to a robotic approach.

In SMART technique he recreates the classic open anatomic RRP technique as closely as possible on the robotic platform.

Learn more

Prostate cancer

Prostate cancer is a malignant tumor that forms in the prostate gland of the male reproductive system. It is one of the most common types of cancer diagnosed in American men, over the age of 50. More than 200,000 new cases are diagnosed each year in the United States. As with most cancers, prostate cancer is not contagious. Recently, the overall 5-year survival rates for all stages of prostate cancer have increased from 69% to nearly 100%.

This change is a result of early detection and better treatment methods, in particular minimally invasive robotic surgery.

The main function of the prostate is to produce semen, which transports sperm during ejaculation. Normally, the prostate is small, about the size and shape of a walnut. The prostate gland is located below the bladder, encircles the urethra, and is in front of the rectum.

Learn More
Prostate cancer

Smart surgery

SMART Surgery Technique (Samadi Modified Advanced Robotic Technique). Having completed fellowship training in both urologic oncology and laparoscopy, Dr Samadi’s technique builds on oncologic principles learned with open radical prostatectomy and transferred to a robotic approach.

In SMART technique he recreates the classic open anatomic RRP technique as closely as possible on the robotic platform. He does not view the robot as a good unto itself, but, rather, as a tool that permits enhanced anatomic radical prostatectomy by improving vision and allowing angles of dissection not possible with open or straight laparoscopic instruments.

Learn More
Smart surgery

Treatment Trifecta

Three is a very important number to Dr. David Samadi, Chairman of Urology, and Chief of Robotic Surgery at Lenox Hill Hospital. Considered a mystical number, Samadi has incorporated this number in his robotic prostatectomy practice. Having performed over 7,000+ successful prostate cancer treatments in his work, Samadi’s experience is unparalleled.

Thanks to three fellowships, he is not only an accomplished robotic surgeon, he is also expertly trained in open and laparoscopic surgery. Samadi refers to himself as "three surgeons in one head,” which is crucial in surgery, if he needed to switch from one type of surgery to another.

Learn More
Treatment Trifecta
Meet Dr. David Samadi

Meet Dr. David Samadi

David B. Samadi, MD is the Chairman of Urology, and Chief of Robotic Surgery at Lenox Hill Hospital in New York City.

As a board-certified urologist and an oncologist specializing in the diagnosis and treatment of urologic diseases, kidney cancer, bladder cancer, and prostate cancer, he also specializes in many advanced minimally invasive treatments for prostate cancer, including laparoscopic radical prostatectomy and laparoscopic robotic radical prostatectomy.

Learn more CONTACT DR. SAMADI   
See all testimonials   

Videos

See all videos   

Health Articles

Androgen Deprivation Therapy Associated With Increased Risk Of Cardiovascular Disease

The potential association between androgen deprivation therapy (ADT) and cardiovascular disease has remained controversial. A recent study found an association that...

Read more  

Prostate Cancer Patients Improve Bone Health with Osteoporosis Drugs by Dr David Samadi

It is well known that men who receive androgen deprivation therapy (ADT) after diagnosis of prostate cancer can experience significant bone loss as side effect of treatment. A...

Read more  

Black Men’s Prostate Cancer Survival Partially Dependent On Racial Differences In Definitive Therapy By Dr David Samadi

Researchers, using the National Cancer Data Base, found at most U.S. medical facilities, white men are more likely than black men to receive definitive therapy (surgery and/or...

Read more